BBLG
Bone Biologics Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.56
+0.39%Aug 12, 2026, 12:00 UTC
Bone Biologics Corporation announced that the validated shelf life of its rhNELL-1 protein has been extended to 32 months, enhancing manufacturing and distribution flexibility ahead of pivotal-study scale.
Source:Jul 9, 2026, 00:00 UTC
Bone Biologics Corp signed a $3.0 million at-the-market private placement agreement with an institutional investor, issuing common stock and pre-funded warrants, plus Series F and Series G warrants, with $3.0 million in upfront gross proceeds and up to $6.0 million additional from warrant exercises.